Health Equity

(B-197) A Fair Individualized Risk Score for Identifying Risks of Falls among Patients with Alzheimer Disease and Related Dementia

(B-194) Association between older adults’ socioeconomic status and their healthcare experiences, preferences, and attitudes towards medications: A cross-sectional study in 14 countries

(B-184) Equity in Pharmacoepidemiology: Improving Understanding of Use, Benefits, and Risks of Medicinal Products in Human Populations

(B-190) Estimating Prevalence for 50 Common Nonfatal Health Conditions by Race/Ethnicity and County in the United States, Incorporating a Novel Correction for Healthcare Access Disparities

(B-185) Evaluation of Productivity Losses Due to Premature Mortality from Head and Neck Cancer in Northeast India: a population-based cost analysis

(B-186) Impact of social determinants of health on receipt of guideline-concordant infection prophylaxis among Medicare beneficiaries with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

(B-187) Inequities in the Use of Orally-administered Antimyeloma Therapies Granted Accelerated Approval

(B-196) Making it CLEAR: Using An AI-Assisted Health Literacy Tool to Increase Health Equity in Healthcare and Research

(B-195) Real-World Data Considerations to Generate Estimates of Race and Ethnicity Distributions for Clinical Trial Diversity Plans

(B-189) Representativeness of Vulnerable Populations in Randomized Controlled Trials Evaluating the Efficacy and Safety of SGLT-2 Inhibitors: A Systematic Review and Meta-analysis

(B-188) Safety and Effectiveness of Cemiplimab in Combination with Platinum-Doublet Chemotherapy by Demographic Characteristics in First-Line Treatment of Advanced Non-Small Cell Lung Cancer: An Ongoing Real World Evidence Study

(B-191) Setting diversity goals for clinical trials: Epidemiologic considerations